SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-046289
Filing Date
2021-04-05
Accepted
2021-04-05 06:55:15
Documents
15
Period of Report
2021-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2112090d1_8k.htm   iXBRL 8-K 29155
2 EXHIBIT 10.1 tm2112090d1_ex10-1.htm EX-10.1 49196
3 EXHIBIT 99.1 tm2112090d1_ex99-1.htm EX-99.1 10508
4 GRAPHIC tm2112090d1_ex99-1img001.jpg GRAPHIC 5742
  Complete submission text file 0001104659-21-046289.txt   290029

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA isee-20210404.xsd EX-101.SCH 3193
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE isee-20210404_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isee-20210404_pre.xml EX-101.PRE 22715
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2112090d1_8k_htm.xml XML 3600
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 21803701
SIC: 2834 Pharmaceutical Preparations